Department of Cardiology, Ulleval University Hospital, 0407 Oslo, Norway.
Europace. 2009 Oct;11(10):1301-7. doi: 10.1093/europace/eup220. Epub 2009 Aug 6.
To evaluate the effects of the angiotensin II type 1 receptor blocker candesartan on P-wave signal-averaged electrocardiogram (P-SAECG) after electrical cardioversion in patients with atrial fibrillation (AF).
One hundred and seventy-one patients with persistent AF were randomized to receive candesartan 8 mg/day or placebo for 3-6 weeks before and candesartan 16 mg/day or placebo for 6 months after electrical cardioversion. P-SAECG was recorded in 114 patients (57 in each treatment group) after cardioversion and repeated in those with sinus rhythm at 1 and 6 weeks, and 3 and 6 months. Filtered P-wave duration (FPD), root-mean-squared (RMS) voltages of the terminal 40 ms of the filtered P-wave, RMS voltage of the entire filtered P-wave, and the integral of the voltages in the entire PD were analysed. No effects of candesartan were observed on any P-SAECG parameter at baseline. In the subgroup of patients in sinus rhythm after 6 months, FPD was significantly shorter both at baseline (151 +/- 16 vs. 163 +/- 16 ms) and at 6 months (143 +/- 12 vs. 153 +/- 15 ms) in the candesartan (n = 15) compared with the placebo group (n = 21).
Treatment with candesartan was associated with a shorter FPD in patients remaining in sinus rhythm for 6 months.
评估血管紧张素Ⅱ 1 型受体拮抗剂坎地沙坦对持续性心房颤动(AF)患者电复律后 P 波信号平均心电图(P-SAECG)的影响。
171 例持续性 AF 患者被随机分为坎地沙坦 8mg/天组或安慰剂组,在电复律前 3-6 周和电复律后 6 个月给予坎地沙坦 16mg/天或安慰剂。114 例患者(每组 57 例)在电复律后记录 P-SAECG,并在窦性心律时于 1、6 周和 3、6 个月重复记录。分析滤波 P 波时限(FPD)、滤波 P 波终末 40ms 均方根电压(RMS)、滤波 P 波总 RMS 电压和整个 P 波电压积分。坎地沙坦对任何 P-SAECG 参数在基线时均无影响。在 6 个月时窦性心律的患者亚组中,坎地沙坦组(n=15)的 FPD 在基线时(151±16 比 163±16ms)和 6 个月时(143±12 比 153±15ms)均显著缩短,而安慰剂组(n=21)则无变化。
坎地沙坦治疗可使 6 个月时仍保持窦性心律的患者的 FPD 缩短。